toujeo max

Generic: insulin glargine

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name toujeo max
Generic Name insulin glargine
Labeler a-s medication solutions
Dosage Form INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

insulin glargine 300 U/mL

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-4177
Product ID 50090-4177_49a2c875-471e-4f82-90bd-b6997234d4e6
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA206538
Listing Expiration 2026-12-31
Marketing Start 2015-02-15

Pharmacologic Class

Established (EPC)
insulin analog [epc]
Chemical Structure
insulin [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500904177
Hyphenated Format 50090-4177

Supplemental Identifiers

RxCUI
2002419 2002420
UNII
2ZM8CX04RZ
NUI
M0011417 N0000175453

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name toujeo max (source: ndc)
Generic Name insulin glargine (source: ndc)
Application Number BLA206538 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 300 U/mL
source: ndc
Packaging
  • 2 SYRINGE in 1 CARTON (50090-4177-0) / 3 mL in 1 SYRINGE
source: ndc

Packages (1)

Ingredients (1)

insulin glargine (300 U/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "49a2c875-471e-4f82-90bd-b6997234d4e6", "openfda": {"nui": ["M0011417", "N0000175453"], "unii": ["2ZM8CX04RZ"], "rxcui": ["2002419", "2002420"], "spl_set_id": ["620b9a3d-8d8c-4c0a-b5a2-f269d6cc9ab9"], "pharm_class_cs": ["Insulin [CS]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "2 SYRINGE in 1 CARTON (50090-4177-0)  / 3 mL in 1 SYRINGE", "package_ndc": "50090-4177-0", "marketing_start_date": "20190311"}], "brand_name": "TOUJEO Max", "product_id": "50090-4177_49a2c875-471e-4f82-90bd-b6997234d4e6", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Insulin Analog [EPC]", "Insulin [CS]"], "product_ndc": "50090-4177", "generic_name": "insulin glargine", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TOUJEO Max", "active_ingredients": [{"name": "INSULIN GLARGINE", "strength": "300 U/mL"}], "application_number": "BLA206538", "marketing_category": "BLA", "marketing_start_date": "20150215", "listing_expiration_date": "20261231"}